Certara Scientists are Among the Topmost Cited Biopharma Researchers
Certara celebrates its 200 published papers and 11 scientists ranked in the top 2% of…
Certara2025 年 10 月 20 日
Certara IQ™: The Future of AI-Enabled Scalable QSP Modeling
Explore how Certara IQ redefines QSP modeling through automation, scalability, and AI assistance for faster,…
Certara2025 年 10 月 16 日
Immuno-oncology (IO) Simulator in Certara IQ™
Learn how Certara IQ’s IO Simulator models immune-tumor interactions and therapy outcomes to guide immuno-oncology…
Certara2025 年 10 月 16 日
ADC Modeling and Design with Certara IQ™
Discover how Certara IQ helps optimize antibody-drug conjugate properties through mechanistic modeling and early feasibility…
Certara2025 年 10 月 16 日
Prebuilt Pharmacology Models in Certara IQ™
Certara IQ Pharmacology Models | Prebuilt Mechanistic Models for Faster QSP Research
Certara2025 年 10 月 16 日
QSP Modeling for Inflammatory Bowel Disease (IBD) with Certara IQ™
Learn how Certara IQ’s IBD model enables simulation of complex immune pathways to optimize therapeutic…
Certara2025 年 10 月 16 日
Modeling Alzheimer’s Disease with Certara IQ™
Explore Certara IQ’s Alzheimer’s Disease model, enabling researchers to simulate neurodegenerative pathways, test therapies, and…
Certara2025 年 10 月 16 日
Early Feasibility Assessment (EFA) with Certara IQ™
Learn how Certara IQ performs early feasibility assessments (EFA) to predict biotherapeutic dosing, guide candidate…
Certara2025 年 10 月 16 日
Certara IQ™: Predicting Recommended Phase 2 Doses with Confidence
Learn how Certara IQ predicts recommended Phase 2 doses using advanced QSP modeling workflows that…
Certara2025 年 10 月 16 日
Certara IQ™: Model-Informed First-In-Human (FIH) Dose Selection
Discover how Certara IQ uses QSP modeling to predict safe and effective First-In-Human doses, accelerating…
Certara2025 年 10 月 16 日
